Lech Krawczyk

Lech Krawczyk

Auto-generated profile, based on publicly available information

Lech Krawczyk

Department of Anaesthesiology and Intensive Therapy, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2003 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
GZG. Zanetti
G. Zanetti
FBF. Bally
F. Bally
Gilbert GREUBGilbert GREUB
Gilbert GREUB
JGJ. Garbino
J. Garbino
TKT. Kinge
T. Kinge
TGthe Cefepime Study Group
the Cefepime Study Group
In a randomized, evaluator-blind, multicenter trial, we compared cefepime (2 g three times a day) with imipenem-cilastatin (500 mg four times a day) for the treatment of nosocomial pneumonia in 281 intensive care unit patients from 13 centers in six European countries. Of 209 patients eligible for per-protocol analysis of efficacy, favorable clinical responses were achieved in 76 of 108 (70%) patients treated with cefepime and 75 of 101 (74%) patients treated with imipenem-cilastatin. The 95% confidence interval (CI) for the difference between these response rates (−16 to 8%) failed to exclude the predefined lower limit for noninferiority of −15%. In addition, therapy of pneumonia caused by an organism producing an extended-spectrum β-lactamase (ESBL) failed in 4 of 13 patients in the cefepime group but in none of 10 patients in the imipenem group. However, the clinical efficacies of both treatments appeared to be similar in a secondary intent-to-treat analysis (95% CI for difference, −9 to 14%) and a multivariate analysis (95% CI for odds ratio, 0.47 to 1.75). Furthermore, the all-cause 30-day mortality rates were 28 of 108 (26%) patients in the cefepime group and 19 of 101 (19%) patients in the imipenem group ( P = 0.25). Rates of documented or presumed microbiological eradication of the causative organism were similar with cefepime (61%) and imipenem-cilastatin (54%) (95% CI, −23 to 8%). Primary or secondary resistance of Pseudomonas aeruginosa was detected in 19% of the patients treated with cefepime and 44% of the patients treated with imipenem-cilastatin ( P = 0.05). Adverse events were reported in 71 of 138 (51%) and 62 of 141 (44%) patients eligible for safety analysis in the cefepime and imipenem groups, respectively ( P = 0.23). Although the primary end point for this study does not exclude the possibility that cefepime was inferior to imipenem, some secondary analyses showed that the two regimens had comparable clinical and microbiological efficacies. Cefepime appeared to be less active against organisms producing an ESBL, but primary and secondary resistance to imipenem was more common for P. aeruginosa . Selection of a single agent for therapy of nosocomial pneumonia should be guided by local resistance patterns.

1 September 2018 in Journal of Infection and Public Health
Verified
Journal Article
Open access
GZGrzegorz Ziółkowski
Grzegorz Ziółkowski
IPIwona Pawłowska
Iwona Pawłowska
LKLech Krawczyk
Lech Krawczyk
Jadwiga Wójkowska-MachJadwiga Wójkowska-Mach
Jadwiga Wójkowska-Mach
Acinetobacter baumannii strains are currently the most commonly isolated non-fermenting rods at Polish intensive care units (ICUs), and they are the dominant aetiological agents of pneumonia. This study aimed to evaluate the prevalence of A. baumannii isolated from patients who were hospitalised at Sosnowiec Hospital's ICU. We also investigated the drug sensitivity of A. baumannii in relation to antibiotic consumption expressed as the defined daily dose (DDD) and Clostridium difficile infection (CDI). We performed a retrospective, laboratory-based study, which comprised consecutive, non-repetitive A. baumannii isolates from bloodstream infections and patients with pneumonia who were hospitalised from 2014-2015. In the analysed period, 187 A. baumannii strains constituted 13.5% of all pathogens from clinical samples. A total of 76.5% of these strains were extensively drug resistant. Resistance of A. baumannii to fluoroquinolones, amikacin, and trimethoprim/sulfamethoxazole exceeded 90%. A total of 95% of strains were resistant to imipenem and meropenem, and 100% were resistant to cephalosporins and tetracyclines. Antibiotic consumption was 191.54 DDD for 100 patient-days, and the highest use of antibiotics involved ampicillin with sulbactam. The cumulative CDI incidence rate was 2.4%. In our ICU, all of the strains were extensively drug resistant and sensitive to colistin. The significantly high consumption of carbapenems, fluoroquinolones, and aminoglycosides should be reduced because the high CDI incidence is probably related to extensive antibiotic consumption.

1 January 2011 in Journal of Pediatric Orthopaedics B
Verified
Journal Article
Closed access
RNRoman Nowak
Roman Nowak
MMMariusz Maliszewski
Mariusz Maliszewski
LKLech Krawczyk
Lech Krawczyk
To report a case of acute intracranial subdural hematoma, pneumocephalus, and pneumorachis, which occurred because of cerebrospinal fluid (CSF) leak caused by a malpositioned transpedicular screw during spinal surgery for severe myelodysplastic scoliosis accompanied with hydrocephalus. Intracranial hemorrhage may occur as a consequence of dural sac penetration and CSF leakage after various medical procedures at the spinal level. The awareness of this severe complication is especially important during spinal instrumentation procedures in which inadvertent dural sac violation and CSF loss may be overlooked. A case report and literature review are presented here. A 12-year-old girl with a history of myelomeningocele and hydrocephalus underwent instrumentation for severe myelodysplastic scoliosis. Postoperatively, she became aphasic and increasingly somnolent. An urgent computed tomographic scan of the head and spine showed massive intracranial hematoma, pneumocephalus, pneumorachis, and a malpositioned pedicular screw that caused CSF leakage, intracranial hypotension, and bleeding remote from the surgical site. The patient needed neurosurgical cranial decompression and subsequent spinal reoperation with dural tear repair. The final outcome was an uneventful complete recovery. The increasing use of pedicular screws in spinal surgery carries a potential risk of occult dural sac violation with subsequent CSF leakage, intracranial hypotension, and the possibility of intracranial bleeding and pneumocephalus remote from the surgical site. This potentially fatal complication should always be considered after spinal surgery in the presence of early signs of neurological deterioration and necessitates an urgent cranial and spinal imaging to confirm the diagnosis and to make adequate treatment decisions.

10 August 2004 in Inflammation Research
Verified
Journal Article
Closed access
PDF file
PDP. Dziurdzik
P. Dziurdzik
LKL. Krawczyk
L. Krawczyk
PJPrzemysław Olaf Jałowiecki
Przemysław Olaf Jałowiecki
ZKZ. Kondera-Anasz
Z. Kondera-Anasz
LML. Menon
L. Menon

31 March 2019 in Anaesthesiology Intensive Therapy
Verified
Journal Article
Open access
PDF file
MSMichał Jan Stasiowski
Michał Jan Stasiowski
RMRadosław Marciniak
Radosław Marciniak
ADAnna Duława
Anna Duława
LKLech Krawczyk
Lech Krawczyk
PJPrzemysław Olaf Jałowiecki
Przemysław Olaf Jałowiecki
Background: The aim of the study was to assess the influence of volatile induction of general anaesthesia with sevoflurane using two different techniques and intravenous anaesthesia with propofol on the possible presence of epileptiform electroencephalograph patterns during the induction of general anaesthesia. Methods: Sixty patients (age 18-70 years) were recruited. Exclusion criteria included history of epilepsy, neurological or neurosurgical diseases, pre-existing EPs in initial EEG recordings, medication interfering with EEG patterns. Patients were randomly allocated into three different groups: A (sevoflurane, increasing concentrations technique); B (sevoflurane, vital capacity technique); C (intravenous propofol). The clinical and instrumental monitoring included arterial blood pressure, heart rate, standard electrocardiography II, arterial oxygen saturation, facial electromyography, fraction of inspired sevoflurane, fraction of expired sevoflurane, minimal alveolar concentration of sevoflurane, and BIS. Results: Neurophysiological analysis of EEGs showed different EPs: polyspikes (PS), rhythmic polyspikes (PSR), and periodic epileptiform discharges (PED). EPs (p < 0.05) were observed in Group A (56%) and Group B (37%), but not in Group C. One patient in group B presented with clinical seizures. No significant differences in the vital parameters and anaesthesia parameters between groups was observed, regardless of the presence of EPs, which were associated with both low and more likely high (falsely indicating awakening from anaesthesia) BIS scores. Conclusion: Our study shows that the BIS score variations do not detect epileptiform activity, which was associated with both low and high scores. The sevoflurane concentration reached either sedative or toxic concentrations. Background: The aim of the study was to assess the influence of volatile induction of general anaesthesia with sevoflurane using two different techniques and intravenous anaesthesia with propofol on the possible presence of epileptiform electroencephalograph patterns during the induction of general anaesthesia. Methods: Sixty patients (age 18-70 years) were recruited. Exclusion criteria included history of epilepsy, neurological or neurosurgical diseases, pre-existing EPs in initial EEG recordings, medication interfering with EEG patterns. Patients were randomly allocated into three different groups: A (sevoflurane, increasing concentrations technique); B (sevoflurane, vital capacity technique); C (intravenous propofol). The clinical and instrumental monitoring included arterial blood pressure, heart rate, standard electrocardiography II, arterial oxygen saturation, facial electromyography, fraction of inspired sevoflurane, fraction of expired sevoflurane, minimal alveolar concentration of sevoflurane, and BIS. Results: Neurophysiological analysis of EEGs showed different EPs: polyspikes (PS), rhythmic polyspikes (PSR), and periodic epileptiform discharges (PED). EPs (p < 0.05) were observed in Group A (56%) and Group B (37%), but not in Group C. One patient in group B presented with clinical seizures. No significant differences in the vital parameters and anaesthesia parameters between groups was observed, regardless of the presence of EPs, which were associated with both low and more likely high (falsely indicating awakening from anaesthesia) BIS scores. Conclusion: Our study shows that the BIS score variations do not detect epileptiform activity, which was associated with both low and high scores. The sevoflurane concentration reached either sedative or toxic concentrations.

1 December 2017 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Closed access
MPMonika Pomorska-Wesołowska
Monika Pomorska-Wesołowska
ACAgnieszka Chmielarczyk
Agnieszka Chmielarczyk
MCMonika Chlebowicz
Monika Chlebowicz
GZGrzegorz Ziółkowski
Grzegorz Ziółkowski
ASAnna Szczypta
Anna Szczypta
Jadwiga Wójkowska-MachJadwiga Wójkowska-Mach
Jadwiga Wójkowska-Mach